glp-1 receptor agonist news agonists show promise in treating substance use disorders The Power of Discovery: GLP-1

Toxicities of opioid analgesics: respiratory depression, histamine release, hemodynamic changes, hypersensitivity, serotonin toxicity

H., et al

This effect was fully suppressed by the microglial inhibitor minocycline and the p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580, underscoring the essential role of microglial activation and the p38 MAPK pathway [72]

[DOI] [PMC free article] [PubMed] [Google Scholar] 88.Zhu H.L., Zhang Y.S., Shi Z.S., Lu D., Li T., Ding Y., Ruan Y., Xu A

Inject your GLP-1 medicine under the skin in one of these areas: The stomach at least 2 inches from the belly button, the outer thigh or the back of your upper arm

Harkavyi A, Rampersaud N, Whitton PS